BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27214087)

  • 21. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C; Tarnow L; Goetze JP; Rossing P
    Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydronephrosis is associated with elevated plasmin in urine in pediatric patients and rats and changes in NCC and γ-ENaC abundance in rat kidney.
    Zachar R; Al-Mashhadi A; Dimke H; Svenningsen P; Jensen BL; Carlström M
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F547-F557. PubMed ID: 29767556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Urinary Plasminogen-Plasmin with Edema and Epithelial Sodium Channel Activation in Patients with Nephrotic Syndrome.
    Chen JL; Wang L; Yao XM; Zang YJ; Wang Y; Li ZJ; Pearce D; Wang H
    Am J Nephrol; 2019; 50(2):92-104. PubMed ID: 31269481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Epithelial Sodium Channel ENaC and the Apical Cl-/HCO3- Exchanger Pendrin in Compensatory Salt Reabsorption in the Setting of Na-Cl Cotransporter (NCC) Inactivation.
    Patel-Chamberlin M; Varasteh Kia M; Xu J; Barone S; Zahedi K; Soleimani M
    PLoS One; 2016; 11(3):e0150918. PubMed ID: 26963391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter.
    Lurbe A; Fioretto P; Mauer M; LaPointe MS; Batlle D
    Kidney Int; 1996 Nov; 50(5):1684-93. PubMed ID: 8914037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of renal NaCl retention in proteinuric disease.
    Svenningsen P; Friis UG; Versland JB; Buhl KB; Møller Frederiksen B; Andersen H; Zachar RM; Bistrup C; Skøtt O; Jørgensen JS; Andersen RF; Jensen BL
    Acta Physiol (Oxf); 2013 Mar; 207(3):536-45. PubMed ID: 23216619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance.
    Vedovato M; Lepore G; Coracina A; Dodesini AR; Jori E; Tiengo A; Del Prato S; Trevisan R
    Diabetologia; 2004 Feb; 47(2):300-3. PubMed ID: 14704836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Na(+) dependence of K(+) -induced natriuresis, kaliuresis and Na(+) /Cl(-) cotransporter dephosphorylation.
    Jensen IS; Larsen CK; Leipziger J; Sørensen MV
    Acta Physiol (Oxf); 2016 Sep; 218(1):49-61. PubMed ID: 27172453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of postural change on urine volume and urinary sodium excretion in diabetic nephropathy.
    Ogi M; Kojima S; Kuramochi M
    Am J Kidney Dis; 1998 Jan; 31(1):41-8. PubMed ID: 9428450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular control of kidney epithelial transporters.
    Sparks MA; Dilmen E; Ralph DL; Rianto F; Hoang TA; Hollis A; Diaz EJ; Adhikari R; Chew G; Petretto EG; Gurley SB; McDonough AA; Coffman TM
    Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1080-F1092. PubMed ID: 33969697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report.
    Hinrichs GR; Mortensen LA; Jensen BL; Bistrup C
    Physiol Rep; 2018 Jun; 6(12):e13743. PubMed ID: 29939487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study.
    Li R; Xie Z; Zhang L; Huang Y; Ma J; Dong W; Li Z; Chen Y; Liang H; Wu Y; Zhao X; Wang W; Ye Z; Liu S; Shi W; Liang X
    Ren Fail; 2021 Dec; 43(1):452-459. PubMed ID: 33657976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial natriuretic peptide and response to changing plasma volume in diabetic nephropathy.
    Lieberman JS; Parra L; Newton L; Scandling JD; Loon N; Myers BD
    Diabetes; 1991 Jul; 40(7):893-901. PubMed ID: 1647996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers.
    Lambers Heerspink HJ; Holtkamp FA; Parving HH; Navis GJ; Lewis JB; Ritz E; de Graeff PA; de Zeeuw D
    Kidney Int; 2012 Aug; 82(3):330-7. PubMed ID: 22437412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity.
    Kamenicky P; Blanchard A; Frank M; Salenave S; Letierce A; Azizi M; Lombès M; Chanson P
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2127-35. PubMed ID: 21508131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes.
    Marre M; Hallab M; Billiard A; Le Jeune JJ; Bled F; Girault A; Fressinaud P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S165-8. PubMed ID: 1725033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy.
    Imanishi M; Yoshioka K; Okumura M; Konishi Y; Tanaka S; Fujii S; Kimura G
    Kidney Int Suppl; 1997 Dec; 63():S198-200. PubMed ID: 9407458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.